Modus Therapeutics Holding AB
MODTX
Rank in Stocks
#32426
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a... Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.
Share Price
$0.01734444
Last synced: 2026-11-09
Market Cap
$1.58M
Change (1 day)
7.23%
Change (1 year)
-55.43%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Modus Therapeutics Holding AB (MODTX)
Category
Healthcare
Earnings for Modus Therapeutics Holding AB (MODTX)
Earnings in Jun 2026 TTM: $-1.78M
According to Modus Therapeutics Holding AB's latest financial reports, its current earnings (TTM) are $-1.78M. In 2025 the company earned $-2.01M, a decrease compared to its 2024 earnings of $-1.41M. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for Modus Therapeutics Holding AB from 2018 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $-1.78M | -11.66% |
| 2025 | $-2.01M | 42.58% |
| 2024 | $-1.41M | -20.55% |
| 2023 | $-1.77M | 0.97% |
| 2022 | $-1.76M | -23.15% |
| 2021 | $-2.29M | 213.91% |
| 2020 | $-728.33K | -84.40% |
| 2019 | $-4.67M | -16.01% |
| 2018 | $-5.56M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $4.76B | -268,205.24% |
US
|
|
| $-2.73B | 153,626.06% |
US
|
|
| $-4.02B | 226,134.54% |
AU
|
|
| $2.83B | -159,280.14% |
BE
|
|
| $1.50B | -84,423.57% |
NL
|
Questions about Modus Therapeutics Holding AB's net income
What is Modus Therapeutics Holding AB's net income?
Modus Therapeutics Holding AB's net income over the last twelve months is $-1.78M, as of Jun 2026.
What was Modus Therapeutics Holding AB's net income in 2025?
In 2025, Modus Therapeutics Holding AB's net income was $-2.01M, compared with $-1.41M in 2024.
How has Modus Therapeutics Holding AB's net income changed since 2020?
From 2020 to 2025, Modus Therapeutics Holding AB's net income was highest in 2020 ($-728.33K) and lowest in 2021 ($-2.29M).
How does Modus Therapeutics Holding AB's net income compare with similar companies?
Modus Therapeutics Holding AB's net income ($-1.78M) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $4.76B.